Table 1.
MASQ |
|||||
---|---|---|---|---|---|
Mean | Stdev | Total | AC | VM | |
MASQ Total Score and Subscales (Verbal Memory and Attention) | |||||
MASQ Total | 93.24 | 23.90 | |||
MASQ Attention (AC) | 15.64 | 4.61 | 0.892** | ||
MASQ Verbal Memory (VM) | 17.16 | 5.28 | 0.901** | 0.770** | |
Post-treatment changes in neurocognitive tests | |||||
CVLT-2-LDFR | 0.28 | 0.92 | −0.090 | −0.089 | −0.051 |
CVLT-2-Trial 1 | −0.05 | 1.25 | −0.006 | −0.043 | −0.034 |
CVLT-2-MRR | 0.09 | 1.08 | −0.082 | −0.008 | −0.016 |
CVLT-2-List B | −0.18 | 0.98 | −0.052 | −0.025 | −0.053 |
PASAT 2″ | 0.34 | 0.71 | −0.124 | −0.087 | −0.109 |
D-KEFS TMT-Visual Scanning | 0.07 | 0.62 | −0.049 | 0.006 | −0.134 |
D-KEFS TMT-Number Sequencing | 0.22 | 1.01 | −0.200* | −0.195* | −0.131 |
D-KEFS TMT-Letter Sequencing | 0.31 | 0.93 | −0.278** | −0.244** | −0.286** |
D-KEFS CWI-Color Naming | 0.002 | 0.74 | −0.003 | −0.002 | 0.035 |
D-KEFS CWI-Word Reading | −0.13 | 0.60 | −0.030 | −0.042 | −0.064 |
D-KEFS CWI-Inhibition | 0.18 | 0.65 | −0.055 | −0.058 | −0.080 |
CPT-Distractibility | 0.05 | 0.87 | 0.006 | 0.020 | 0.041 |
CPT-Vigilance | 0.16 | 0.65 | −0.017 | 0.009 | 0.005 |
Notes: Listed are the Pearson correlation coefficients between the MASQ scores measured at 6 months post-treatment and the changes of neurocognitive performance between baseline and 6 months post treatment. The MASQ was scored so that a higher score represented worse outcomes (greater problems or issues). Thus, a negative correlation was the anticipated direction of correlation, meaning that a decline in neurocognitive performance at 6-months post-treatment was associated with more self-reported MASQ problems.
*p < .05; **p < .01.